Kristen Kluska
Equity research analyst · Cancer Fitzgerald
Earnings calls
1
Nov 16, 2026 – Nov 16, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Kristen Kluska asked questions on (from Lician's transcripts).
Questions on earnings calls
- LXEO earnings call · Lexeo Therapeutics, Inc.Nov 16, 2026 · 1 question
- 43:07
“I was hoping you could characterize some of the natural history work for us and how well understood these patients are assuming not on any treatment. I know there's heterogeneity, of course, on a patient-by-patient difference, but for the most part, do we see that most patients…”
- 43:07
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
Cancer Fitzgerald rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Kristen Kluska. We do not use licensed rating databases.
No rating action by Cancer Fitzgerald on these stocks in the headlines we store yet.